ArticleJournal of bone oncology2014

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin.

Peggy Benad-Mehner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.